Intuitive Surgical (NASDAQ:ISRG) Sets New 1-Year High - Still a Buy?

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report)'s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as $562.00 and last traded at $558.46, with a volume of 163335 shares traded. The stock had previously closed at $538.88.

Analyst Ratings Changes

Several research firms have recently weighed in on ISRG. Leerink Partners lifted their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an "overweight" rating in a report on Wednesday, December 11th. Mizuho increased their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. BTIG Research lifted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. Finally, Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $554.17.

Intuitive Surgical Stock Performance

The company has a market cap of $211.09 billion, a PE ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. The firm's 50 day moving average is $539.54 and its 200-day moving average is $497.69.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 2,128 shares of the company's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Brian Edward Miller sold 2,553 shares of the firm's stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the sale, the executive vice president now directly owns 7,066 shares of the company's stock, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock worth $25,012,927 in the last three months. 0.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently modified their holdings of ISRG. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $36,000. Mark Sheptoff Financial Planning LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $37,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical in the 3rd quarter valued at approximately $38,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.